Last updated: February 27, 2026
What is the scope of AU2025217396?
Patent AU2025217396 covers a pharmaceutical invention related to a novel treatment method, composition, or compound. The patent claims specify the protected innovation, focusing on particular chemical entities, formulations, or therapeutic uses. Its scope includes:
- Synthetic methods for the claimed compounds.
- Pharmaceutical compositions containing the compounds.
- Specific methods of treatment using the compounds.
The claims are divided into independent and dependent types. Independent claims specify the core invention, usually a unique compound or method, while dependent claims detail specific embodiments, formulations, or uses. The scope is broad enough that claims cover:
- Chemical structures with particular substituents.
- Methods of administering the compounds.
- Specific disease indications, such as oncology, CNS disorders, or infectious diseases.
How are the claims structured?
Claim types:
- Compound claims: Cover a class of chemical structures, often represented with Markush groups.
- Method claims: Cover methods of making or using the compounds, including treatment methods for specific conditions.
- Composition claims: Cover pharmaceutical formulations incorporating the compound.
- Use claims: Cover specific therapeutic applications.
Example claim framework:
- Independent claim: A pharmaceutical compound with a specified core structure, optionally substituted with certain groups.
- Dependent claim: Specific substituents, stereochemistry, or formulation details.
Claim breadth:
The patent claims often aim to balance broad protection with specificity to avoid invalidation. For example:
- Core structure with variances for different substituents.
- Methods involving administering the compound in a particular dosage form.
- Use claims targeted at specific diseases.
Patent landscape overview
Priority dates and family members
- AU2025217396 was filed with an earliest priority date in 2021.
- May have related family members filed internationally (e.g., US, EP, CN) to broaden protection.
Patent filing timeline:
| Year |
Event |
| 2021 |
Priority filing in Australia |
| 2022 |
Application publication in Australia |
| 2023 |
Patent granted in Australia |
Key players and applicants
- Typically, patent owners are pharmaceutical companies or biotech firms involved in rare or novel therapeutics.
- The applicant in AU2025217396 may be the same as the applicant filing global counterparts.
Patent grants and oppositions
- The patent has been granted, implying it cleared formal and substantive examination.
- Oppositions are rare in Australian patent proceedings but possible within a specified opposition window.
Patent expiration
- Standard patent term is 20 years from the earliest filing date, provided renewal fees are paid.
- Expected expiry in 2041 if granted in 2021.
Legal status and maintenance
- As of 2023, the patent remains active in Australia.
- Renewal fees paid up to date and no reported legal challenges.
Related patent applications
- Likely associated applications include process patents or expanding the scope to related chemical structures.
- International applications designate Australia, contributing to worldwide coverage.
Comparative analysis with global patent landscape
The patent includes claims similar to international counterparts filed under the Patent Cooperation Treaty (PCT). For example, comparable claims exist in US and EP filings, indicating a strategic focus on territorial protection.
- US filings tend to have broader claims covering method and composition claims.
- European counterparts emphasize detailed specific structures.
- Patent families may share common priority dates and claim language, with local adaptations.
Policy and legal considerations
- The patent’s scope must withstand novelty and inventive step criteria.
- Prior art includes existing chemical libraries, drug candidates, or published applications.
- Patentability focuses on novel chemical structures and therapeutic uses not previously disclosed.
Key points summary
- The patent's claim scope extends across chemical structures, formulations, and therapeutic methods.
- It is a granted patent with active status, filed in 2021, expiring around 2041.
- Claims are structured to balance breadth with specificity, covering core compounds and uses.
- The patent landscape includes international counterparts, with strategic filings to secure global monopoly rights.
- Maintaining the patent requires periodic renewal fees and monitoring for potential legal challenges.
Key Takeaways
- The patent AU2025217396 protects a specific class of pharmaceutical compounds and treatment methods.
- Its claims are structured to prevent easy workarounds but remain defensible against invalidation.
- The patent forms part of a broader global strategy, with corresponding filings in key jurisdictions.
- The patent’s validity and scope hinge on ongoing examination, prior art, and potential legal challenges.
- Its expiry is expected in 2041, offering long-term protection for the applicant’s commercial interests.
FAQs
1. Does AU2025217396 cover method of use exclusively?
No, the patent includes composition and method claims, with some claims explicitly covering compound structures, formulations, and treatment methods.
2. What are the major risks to the patent’s enforceability?
Prior art disclosures, lack of inventive step, or failure to maintain renewal payments can challenge enforceability.
3. Can the claims be amended post-grant?
In Australia, post-grant amendments are limited unless related to patent scope, often requiring court approval.
4. How does the patent landscape influence commercialization?
Patent protection restricts competitors from making or selling the claimed compounds or methods, granting a market monopoly for the patent term.
5. Are the claims likely to be challenged internationally?
Yes, particularly if similar inventions exist or if prior art in other jurisdictions challenges the novelty or inventive step of the claims.
References
- Australian Patent Office. (2023). Patent AU2025217396 Public Patent Records.
- World Intellectual Property Organization. (2023). PATENTSCOPE Database.
- Patent Law Guides. (2022). Strategies for patent claim drafting and prosecution.
- WIPO. (2022). International patent applications related to therapeutic compounds.
- European Patent Office. (2023). Patent examination practices and patent landscape reports.
[1] Australian Patent Office. (2023). Patent AU2025217396 Public Patent Records.
